loadpatents
Patent applications and USPTO patent grants for Boyce; Christopher W..The latest application filed is for "methods for preparing stabilized amorphous drug formulations using acoustic fusion".
Patent | Date |
---|---|
Methods for preparing stabilized amorphous drug formulations using acoustic fusion Grant 11,344,496 - Leung , et al. May 31, 2 | 2022-05-31 |
Methods For Preparing Stabilized Amorphous Drug Formulations Using Acoustic Fusion App 20210154138 - Leung; Dennis H. ;   et al. | 2021-05-27 |
Compounds that are ERK inhibitors Grant 10,759,805 - Lim , et al. Sep | 2020-09-01 |
Novel Compounds That Are Erk Inhibitors App 20180319804 - Lim; Jongwon ;   et al. | 2018-11-08 |
Compounds that are ERK inhibitors Grant 10,065,967 - Lim , et al. September 4, 2 | 2018-09-04 |
Novel Compounds That Are Erk Inhibitors App 20170320882 - Lim; Jongwon ;   et al. | 2017-11-09 |
Compounds that are ERK inhibitors Grant 9,745,307 - Lim , et al. August 29, 2 | 2017-08-29 |
Quinoxalines and AZA-quinoxalines as CRTH.sub.2 receptor modulators Grant 9,469,615 - Boyce , et al. October 18, 2 | 2016-10-18 |
Quinolines and aza-quinolines as CRTH.sub.2 receptor modulators Grant 9,290,453 - Boyce , et al. March 22, 2 | 2016-03-22 |
Novel Compounds That Are Erk Inhibitors App 20160068532 - Lim; Jongwon ;   et al. | 2016-03-10 |
Compounds that are ERK inhibitors Grant 9,023,865 - Lim , et al. May 5, 2 | 2015-05-05 |
Quinazolinone-type compounds as CRTH.sub.2 antagonists Grant 8,927,559 - Aslanian , et al. January 6, 2 | 2015-01-06 |
Novel Compounds That Are Erk Inhibitors App 20140296203 - Lim; Jongwon ;   et al. | 2014-10-02 |
Quinoxalines And Aza-quinoxalines As Crth2 Receptor Modulators App 20130303517 - Boyce; Christopher W. ;   et al. | 2013-11-14 |
Quinolines And Aza-quinolines As Crth2 Receptor Modulators App 20130296300 - Boyce; Christopher W. ;   et al. | 2013-11-07 |
Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators Grant 8,569,312 - McCormick , et al. October 29, 2 | 2013-10-29 |
Biaryl-spiroaminooxzaoline Analogues As Alpha 2c Adrenergic Receptor Modulators App 20130225582 - McCormick; Kevin D. ;   et al. | 2013-08-29 |
Quinazolinone-type Compounds As Crth2 Antagonists App 20130210805 - Aslanian; Robert G. ;   et al. | 2013-08-15 |
Functionally selective alpha2C adrenoreceptor agonists Grant 8,501,747 - de lera Ruiz , et al. August 6, 2 | 2013-08-06 |
Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators Grant 8,476,274 - McCormick , et al. July 2, 2 | 2013-07-02 |
Derivatives and analogs of chroman as functionally selective ALPHA2C adrenoreceptor agonists Grant 8,470,863 - Zheng , et al. June 25, 2 | 2013-06-25 |
Reversed Biaryl Spiroaminooxazoline Analogues As Alpha2c Adrenergic Receptor Modulators App 20130079271 - McCormick; Kevin D. ;   et al. | 2013-03-28 |
Functionally selective alpha2C adrenoreceptor agonists Grant 8,383,818 - Zheng , et al. February 26, 2 | 2013-02-26 |
Biaryl Spiroaminooxazoline Analogues As Alpha2c Adrenergic Receptor Modulators App 20130045914 - McCormick; Kevin D. ;   et al. | 2013-02-21 |
Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulators Grant 8,324,213 - McCormick , et al. December 4, 2 | 2012-12-04 |
Functionally Selective Azanitrile Alpha-2c Adrenoreceptor Agonists App 20120028940 - Boyce; Christopher W. ;   et al. | 2012-02-02 |
Biaryl-spiroaminooxazoline Analogues As Alpha 2c Adrenergic Receptor Modulators App 20110251207 - McCormick; Kevin D. ;   et al. | 2011-10-13 |
Functionally selective ALPHA2C adrenoreceptor agonists Grant 8,017,642 - Yu , et al. September 13, 2 | 2011-09-13 |
Functionally selective ALPHA2C adrenoreceptor agonists Grant 8,003,624 - McCormick , et al. August 23, 2 | 2011-08-23 |
Cyclopropylchromene Derivatives As Modulators Of The Alpha-2c Receptor App 20110190247 - Yu; Younong ;   et al. | 2011-08-04 |
ALPHA2C adrenoreceptor agonists Grant 7,985,748 - McCormick , et al. July 26, 2 | 2011-07-26 |
Tricyclic Spirocycle Derivatives And Methods Of Use App 20110166124 - McCormick; Kevin D. ;   et al. | 2011-07-07 |
Functionally Selective Alpha2C Adrenoreceptor Agonists App 20110060006 - Zheng; Junying ;   et al. | 2011-03-10 |
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H.sub.3 antagonists Grant 7,846,946 - Aslanian , et al. December 7, 2 | 2010-12-07 |
Functionally selective alpha2C adrenoreceptor agonists Grant 7,803,828 - McCormick , et al. September 28, 2 | 2010-09-28 |
Functionally Selective Alpha2c Adrenoreceptor Agonists App 20100197562 - De lera Ruiz; Manuel ;   et al. | 2010-08-05 |
Alpha2c Adrenoreceptor Agonists App 20100173823 - McCormick; Kevin D. ;   et al. | 2010-07-08 |
Derivatives And Analogs Of Chroman As Functionally Selective Alpha2c Adrenoreceptor Agonists App 20100168195 - Zheng; Junying ;   et al. | 2010-07-01 |
Functionally Selective Alpha2c Adrenoreceptor Agonists App 20100144816 - McCormick; Kevin D. ;   et al. | 2010-06-10 |
.alpha.2C adrenoreceptor agonists Grant 7,700,592 - McCormick , et al. April 20, 2 | 2010-04-20 |
Phenoxypiperidines and analogs thereof useful as histamine H.sub.3 antagonists Grant 7,638,531 - Mutahi , et al. December 29, 2 | 2009-12-29 |
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H.sub.3 antagonists Grant 7,635,705 - Aslanian , et al. December 22, 2 | 2009-12-22 |
Heteroatom-linked Substituted Piperidines And Derivatives Thereof Useful As Histamine H3 Antagonists App 20090286830 - Aslanian; Robert G. ;   et al. | 2009-11-19 |
Novel Non-imidazole Compounds App 20080119487 - Aslanian; Robert G. ;   et al. | 2008-05-22 |
Alpha2C adrenoreceptor agonists App 20080039439 - McCormick; Kevin D. ;   et al. | 2008-02-14 |
Functionally selective alpha2C adrenoreceptor agonists App 20080027100 - McCormick; Kevin D. ;   et al. | 2008-01-31 |
Non-imidazole compounds Grant 7,300,941 - Aslanian , et al. November 27, 2 | 2007-11-27 |
Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists App 20070167435 - Mutahi; Mwangi W. ;   et al. | 2007-07-19 |
Benzimidazolone histamine H.sub.3 antagonists Grant 7,220,735 - Ting , et al. May 22, 2 | 2007-05-22 |
Functionally selective alpha2C adrenoreceptor agonists App 20070099872 - McCormick; Kevin D. ;   et al. | 2007-05-03 |
Alpha2C adrenoreceptor agonists App 20070093477 - McCormick; Kevin D. ;   et al. | 2007-04-26 |
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists App 20070015807 - Aslanian; Robert G. ;   et al. | 2007-01-18 |
Benzimidazole derivatives useful as histamine H3 antagonists Grant 7,105,505 - Zeng , et al. September 12, 2 | 2006-09-12 |
Benzimidazole derivatives useful as histamine H3 antagonists App 20040097483 - Zeng, Qingbei ;   et al. | 2004-05-20 |
Novel non-imidazole compounds App 20040097513 - Aslanian, Robert G. ;   et al. | 2004-05-20 |
Non-imidazole compounds Grant 6,720,328 - Aslanian , et al. April 13, 2 | 2004-04-13 |
Benzimidazolone histamine H3 antagonists App 20040048843 - Ting, Pauline C. ;   et al. | 2004-03-11 |
Novel non-imidazole compounds App 20030045519 - Aslanian, Robert G. ;   et al. | 2003-03-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.